| Antilymphocyte globulin for prevention of chronic graft-versus-host disease N Kröger, C Solano, C Wolschke, G Bandini, F Patriarca, M Pini, A Nagler, ... New England Journal of Medicine 374 (1), 43-53, 2016 | 543 | 2016 |
| Chronic myeloid leukemia and interferon-α: a study of complete cytogenetic responders F Bonifazi, A de Vivo, G Rosti, F Guilhot, J Guilhot, E Trabacchi, ... Blood, The Journal of the American Society of Hematology 98 (10), 3074-3081, 2001 | 439 | 2001 |
| Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European … O Penack, M Marchetti, T Ruutu, M Aljurf, A Bacigalupo, F Bonifazi, ... The Lancet Haematology 7 (2), e157-e167, 2020 | 422 | 2020 |
| Clinical effects of driver somatic mutations on the outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem-cell transplantation MG Della Porta, A Gallì, A Bacigalupo, S Zibellini, M Bernardi, E Rizzo, ... Journal of clinical oncology 34 (30), 3627, 2016 | 252 | 2016 |
| A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation E Zino, G Frumento, S Marktel, MP Sormani, F Ficara, SD Terlizzi, ... Blood 103 (4), 1417-1424, 2004 | 245 | 2004 |
| Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients PL Zinzani, M Martelli, M Bertini, AM Gianni, L Devizzi, M Federico, ... haematologica 87 (12), 1258-1264, 2002 | 241 | 2002 |
| A randomized study of interferon-α versus interferon-α and low-dose arabinosyl cytosine in chronic myeloid leukemia M Baccarani, G Rosti, A de Vivo, F Bonifazi, D Russo, G Martinelli, ... Blood, The Journal of the American Society of Hematology 99 (5), 1527-1535, 2002 | 234 | 2002 |
| Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin’s lymphoma: identification of prognostic factors predicting outcome SP Robinson, A Sureda, C Canals, N Russell, D Caballero, A Bacigalupo, ... haematologica 94 (2), 230, 2009 | 217 | 2009 |
| Treatment of refractory chronic GVHD with rituximab: a GITMO study F Zaja, A Bacigalupo, F Patriarca, M Stanzani, MT Van Lint, C Fili, ... Bone marrow transplantation 40 (3), 273-277, 2007 | 203 | 2007 |
| Real-time quantitation of minimal residual disease in inv (16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state S Buonamici, E Ottaviani, N Testoni, V Montefusco, G Visani, F Bonifazi, ... Blood, The Journal of the American Society of Hematology 99 (2), 443-449, 2002 | 177 | 2002 |
| Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor … A Dodero, F Spina, F Narni, F Patriarca, I Cavattoni, F Benedetti, F Ciceri, ... Leukemia 26 (3), 520-526, 2012 | 164 | 2012 |
| Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous … S Soverini, M Cavo, C Cellini, C Terragna, E Zamagni, D Ruggeri, ... Blood 102 (5), 1588-1594, 2003 | 163 | 2003 |
| Infliximab treatment for steroid-refractory acute graft-versus-host disease F Patriarca, A Sperotto, D Damiani, G Morreale, F Bonifazi, A Olivieri, ... haematologica 89 (11), 1352-1359, 2004 | 160 | 2004 |
| Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease … P Corradini, A Dodero, L Farina, R Fanin, F Patriarca, R Miceli, ... Leukemia 21 (11), 2316-2323, 2007 | 157 | 2007 |
| Classification and personalized prognostic assessment on the basis of clinical and genomic features in myelodysplastic syndromes M Bersanelli, E Travaglino, M Meggendorfer, T Matteuzzi, C Sala, ... Journal of Clinical Oncology 39 (11), 1223, 2021 | 155 | 2021 |
| Incidence, risk factors and outcome of pre-engraftment gram-negative bacteremia after allogeneic and autologous hematopoietic stem cell transplantation: an Italian prospective … C Girmenia, A Bertaina, A Piciocchi, K Perruccio, A Algarotti, A Busca, ... Clinical Infectious Diseases 65 (11), 1884-1896, 2017 | 136 | 2017 |
| Imatinib and pegylated human recombinant interferon-α2b in early chronic-phase chronic myeloid leukemia M Baccarani, G Martinelli, G Rosti, E Trabacchi, N Testoni, S Bassi, ... Blood 104 (13), 4245-4251, 2004 | 136 | 2004 |
| Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation G Battipaglia, M Labopin, N Kröger, A Vitek, B Afanasyev, I Hilgendorf, ... Blood, The Journal of the American Society of Hematology 134 (11), 892-899, 2019 | 134 | 2019 |
| Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients A Curti, L Ruggeri, S Parisi, A Bontadini, E Dan, MR Motta, S Rizzi, ... Clinical Cancer Research 22 (8), 1914-1921, 2016 | 133 | 2016 |
| Hemopoiesis in healthy old people and centenarians: well-maintained responsiveness of CD34+ cells to hemopoietic growth factors and remodeling of cytokine network GP Bagnara, L Bonsi, P Strippoli, F Bonifazi, R Tonelli, S D'Addato, ... Journals of Gerontology-Biological Sciences and Medical Sciences 55 (2), B61, 2000 | 128 | 2000 |
